Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human) Powder, For Solution
NDC 68982-182
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human) (von willebrand factor/coagulation factor viii complex (human)) is a BLA-approved product labeled by Octapharma Usa Inc. This medication is typically used as a blood coagulation factors [cs]. It is supplied as a powder, for solution for intravenous administration. This product entry covers the primary NDC 68982-182 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
68982-182
Proprietary Name:
Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human)
Non-Proprietary Name: [1]
Von Willebrand Factor/coagulation Factor Viii Complex (human)
Substance Name: [2]
Antihemophilic Factor Human; Von Willebrand Factor Human
NDC Directory Status:
Plasma Derivative
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:
Clinical Specifications
Dosage Form:
Powder, For Solution
- An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution.
Administration Route(s): [4]
Intravenous - Administration within or into a vein or veins.
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
68982
Product Label ID:
HCPCS Code:
J7183
- Wilate injection
FDA Application Number: [6]
BLA125251
Marketing Category: [8]
BLA - A product marketed under an approved Biologic License Application.
Marketing Timeline
Start Marketing Date: [9]
12-04-2009
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
N
Code Structure Chart
Product Details
What is NDC 68982-182?
The NDC code 68982-182 is assigned by the FDA to the product Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human). It is commonly known by its generic name, von willebrand factor/coagulation factor viii complex (human). This pharmaceutical product is labeled by Octapharma Usa Inc and is currently categorized as listed product. The medication is a powder, for solution administered via intravenous route. In terms of distribution, this product is available in 2 different package configurations. The associated package NDC(s) include: 68982-182-01, 68982-182-02. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are the uses of this product?
WILATE is indicated in children and adults with von Willebrand disease for:
On-demand treatment and control of bleeding episodes
Perioperative management of bleeding
WILATE is not indicated for the treatment of hemophilia A.
What are Active Ingredients of this product?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ANTIHEMOPHILIC FACTOR HUMAN (UNII: 839MOZ74GK)
- ANTIHEMOPHILIC FACTOR HUMAN (UNII: 839MOZ74GK) (Active Moiety)
- VON WILLEBRAND FACTOR HUMAN (UNII: ZE22NE22F1)
- VON WILLEBRAND FACTOR HUMAN (UNII: ZE22NE22F1) (Active Moiety)
What is the NDC to RxNorm Crosswalk for this product?
RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
- RxCUI: 1661332 - antihemophilic factor / von Willebrand factor complex, human 1 UNT Injection
- RxCUI: 1661332 - factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection
- RxCUI: 1661332 - factor VIII / von Willebrand Factor complex, human 1 UNT Injection
- RxCUI: 1661335 - wilate (expressed as von Willebrand factor) 1 UNT Injection
- RxCUI: 1661335 - factor VIII, human 1 UNT / von Willebrand factor, human 1 UNT Injection [Wilate]
Which are the Pharmacologic Classes of this product?
A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.
- Blood Coagulation Factors - [CS]
- Blood Coagulation Factors - [CS]
- Factor VIII - [CS]
- Human Antihemophilic Factor - [EPC] (Established Pharmacologic Class)
- Human Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Increased Coagulation Activity - [PE] (Physiologic Effect)
- Increased Platelet Aggregation - [PE] (Physiologic Effect)
- von Willebrand Factor - [CS]
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".
